tetano
Editor, Senior Moderator
Inflamm Bowel Dis
. 2022 Mar 24;izac052.
doi: 10.1093/ibd/izac052. Online ahead of print.
Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study
Mohamed Attauabi[SUP] 1 2 3 [/SUP], Jens Frederik Dahlerup[SUP] 4 [/SUP], Anja Poulsen[SUP] 5 [/SUP], Malte Rosager Hansen[SUP] 6 [/SUP], Marianne Kajbæk Vester-Andersen[SUP] 7 [/SUP], August Pilegaard Prahm[SUP] 5 [/SUP], Natalia Pedersen[SUP] 8 [/SUP], Lone Larsen[SUP] 9 [/SUP], Tine Jess[SUP] 9 10 [/SUP], Anders Neumann[SUP] 11 [/SUP], Kent V Haderslev[SUP] 12 [/SUP], Akbar Molazahi[SUP] 13 [/SUP], Anders Berg Lødrup[SUP] 14 [/SUP], Henning Glerup[SUP] 15 [/SUP], Asser Mathiassen Oppfeldt[SUP] 16 [/SUP], Michael Dam Jensen[SUP] 17 [/SUP], Klaus Theede[SUP] 2 3 [/SUP], Marianne Kiszka-Kanowitz[SUP] 2 3 [/SUP], Jakob Benedict Seidelin[SUP] 1 [/SUP], Johan Burisch[SUP] 2 3 [/SUP]
Affiliations
No abstract availableKeywords: COVID-19 outcomes; disease activity; inflammatory bowel diseases; population-based; sequelae.
Plain Language Summary
This brief report investigated the impact of clinical, biochemical, and endoscopic activity of IBD on the severity and long-term outcomes of COVID-19 in a prospective population-based cohort. The study did not identify any association between IBD activity and COVID-19 outcomes.
. 2022 Mar 24;izac052.
doi: 10.1093/ibd/izac052. Online ahead of print.
Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study
Mohamed Attauabi[SUP] 1 2 3 [/SUP], Jens Frederik Dahlerup[SUP] 4 [/SUP], Anja Poulsen[SUP] 5 [/SUP], Malte Rosager Hansen[SUP] 6 [/SUP], Marianne Kajbæk Vester-Andersen[SUP] 7 [/SUP], August Pilegaard Prahm[SUP] 5 [/SUP], Natalia Pedersen[SUP] 8 [/SUP], Lone Larsen[SUP] 9 [/SUP], Tine Jess[SUP] 9 10 [/SUP], Anders Neumann[SUP] 11 [/SUP], Kent V Haderslev[SUP] 12 [/SUP], Akbar Molazahi[SUP] 13 [/SUP], Anders Berg Lødrup[SUP] 14 [/SUP], Henning Glerup[SUP] 15 [/SUP], Asser Mathiassen Oppfeldt[SUP] 16 [/SUP], Michael Dam Jensen[SUP] 17 [/SUP], Klaus Theede[SUP] 2 3 [/SUP], Marianne Kiszka-Kanowitz[SUP] 2 3 [/SUP], Jakob Benedict Seidelin[SUP] 1 [/SUP], Johan Burisch[SUP] 2 3 [/SUP]
Affiliations
- PMID: 35325137
- DOI: 10.1093/ibd/izac052
No abstract availableKeywords: COVID-19 outcomes; disease activity; inflammatory bowel diseases; population-based; sequelae.
Plain Language Summary
This brief report investigated the impact of clinical, biochemical, and endoscopic activity of IBD on the severity and long-term outcomes of COVID-19 in a prospective population-based cohort. The study did not identify any association between IBD activity and COVID-19 outcomes.